NOSES the world leading patent rights company in the field of Nano Optical Sensor Technologies and Solutions has been acquired by NanoSense Ltd via a share swap and rights issue.

Nanosense Ltd are raising £14.1m to fund the NOSES technology through to commercialisation and deliver £multi million revenues via Breath Test Solutions Ltd and Cabin air Sensor Solutions Ltd. 

The IP, patents and know-how of NOSES has so far successfully  licensed & developed a Global Technology Solution for the aviation industry via Cabin Air Sensor Solutions Ltd (CASS) who are also being acquired. CASS has developed the World’s first portable, real-time organophosphate & poisonous compound sensor for use in aircraft cabins, the product development of this unique solution is on-going and CASS are seeking to deploy it in every commercial aircraft flying in the World today.

NanoSense Ltd have also acquired Breath Test Solutions Ltd (BTS), ChemSense Ltd (CS) & ViruSense Ltd (VS).

ViruSense Ltd is developing the World’s first real-time, portable COVID-19 Virus detector

Breath Test Solutions Ltd is developing a real-time low cost sensor for use by GP’s & Hospitals to detect Volatile Organic Compounds (VOCs) in patient Breath Test samples,  thus assisting in the earlier diagnosis and detection of diseases and certain cancers.

ChemSense Ltd is developing a real-time nerve-agent sensor – drone mounted for use within the Global defence industry.